Neurocrine Biosciences Inc at Bank of America Global Healthcare Conference Transcript
Thanks for joining us. I'm Tazeen Ahmad. I am one of the senior SMID biotech analyst here at Bank of America. Thanks for joining us at our conference again this year. It's my pleasure to present our next management team Neurocrine Biosciences. Sitting with me are too familiar gentlemen. To my left is Kevin Gorman, who is, of course, CEO; and to my right is Matt Abernethy, who is the Chief Financial Officer. Gentlemen, thanks for joining us again.
Thank you very much, Tazeen, and also thank you for letting us speak here again.
Of course. So I think, Kevin, at this point, most people know about the company and what it does, but maybe you could just give us a quick 1-minute intro about Neurocrine and then we can go straight into Q&A.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
